Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enhanced MDA Strategies for Trachoma Elimination in South Sudan
NCT05634759Phase 4Completed
- Sponsor
- Emory University
- Start
- May 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of azithromycin in trachoma (3 arms), sponsored by Emory University. Primary endpoints: Coverage Among Young Children at 12 months, Number of Participants Missing Antibiotic Treatment Round at 12 months and 2 more. Started May 2022; status: completed.
02
Drugs
azithromycin
03
Conditions
trachoma
Beyond the preview
Go deeper on NCT05634759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05634759.